Skip to main content
. 2026 Aug 12;17:1907116. doi: 10.3389/fimmu.2026.1907116

Table 2.

Pretreatment host-state markers by MPR status (full cohort, n=738).

Marker Domain MPR (n=302) Non-MPR (n=436) P
Cortisol, µg/dL Endocrine 11.88 (10.54-13.17) 14.57 (13.10-15.93) <0.001
FT3, pmol/L Endocrine 4.64 (4.44-4.88) 4.28 (4.03-4.48) <0.001
Albumin, g/L Nutrition 42.20 (40.80-43.70) 39.20 (37.60-40.73) <0.001
Prealbumin, mg/L Nutrition 261 (241-284) 216 (194-240) <0.001
PNI Nutrition 51.18 (48.85-53.19) 46.23 (43.69-48.54) <0.001
Vitamin D, ng/mL Micronutrient 26.35 (23.30-29.08) 20.50 (17.80-23.50) <0.001
Lymphocyte, 109/L Inflammation 1.75 (1.59-1.93) 1.42 (1.23-1.59) <0.001
Neutrophil, 109/L Inflammation 3.47 (3.13-3.91) 4.16 (3.79-4.59) <0.001
CRP, mg/L Inflammation 3.09 (2.20-4.47) 6.96 (4.73-10.30) <0.001
NLR Inflammation 1.94 (1.67-2.38) 2.92 (2.39-3.70) <0.001
SII Inflammation 432 (347-577) 734 (548-983) <0.001
CAR Inflammation 0.07 (0.05-0.11) 0.18 (0.12-0.28) <0.001
ENI-Score Score 64.55 (40.17-80.40) 17.45 (6.92-35.60) <0.001

Values are median (IQR); P values are from Mann–Whitney U tests. The direction of every difference was consistent across all three cohorts. FT3, free triiodothyronine; SII, systemic immune-inflammation index; other abbreviations as in Table 1.